Summary Two broodmares were diagnosed with rupture of the urinary bladder. One mare revealed abnormalities post partum and the other associated with ante partum uterine torsion. The clinical symptoms included mild abdominal pain, anorexia, decreased urinary volume and increased peritoneal fluid. In one mare, based on the creatinine level of the peritoneal fluid and serum biochemical abnormalities, uroperitoneum was diagnosed. In the other mare, the bladder rupture was found during the celiotomy for surgical repair of uterine torsion that was diagnosed upon rectal examination. Surgery was performed without a urethral sphincterotomy. The vaginal floor was incised in a standing position and the bladder was diverted into the vagina in order to suture the tears located in the ventrocaudal aspect of the bladder. Both mares survived after treatment for uraemia. Bladder rupture, although uncommon, may affect peripartum mares. Approach to the ruptured bladder without urethral sphincterotomy in a standing position should be considered as a choice for surgical repair.

No abstract

Anaplasma platys infects peripheral blood platelets and causes infectious cyclic thrombocytopenia in canines.The genes, proteins, and antigens of A. platys are largely unknown, and an antigen for serodiagnosis of A. platys has not yet been identified. In this study, we cloned the A. platys major outer membrane protein cluster, including the P44/Msp2 expression locus (p44ES/msp2ES) and outer membrane protein (OMP), using DNA isolated from the blood of four naturally infected dogs from Venezuela and Taiwan

Canine anaplasmosis is regarded as an infection by Anaplasma platys rather than zoonotic Anaplasma phagocytophilum in subtropical areas based on the assumption that the common dog tick species is Rhipicephalus sanguineus, which transmits E. canis and presumably A. platys. We investigated asymptomatic dogs and dog ticks from 16 communities in Nantou County, Taiwan to identify common dog tick species and to determine the prevalence of Anaplasma and Ehrlichia spp. Of total 175 canine blood samples and 315 ticks, including 306 R. sanguineus and 9 Haemaphysalis hystricis, 15 dogs and 3 R. sanguineus ticks were positive for E. canis, while 47 dogs and 71 R. sanguineus ticks were positive for A. platys, via nested PCR for 16S rDNA and DNA sequencing of selected positive amplicons. However, among the dogs and ticks that were positive to A. platys 16S rDNA, only 20 dogs and 11 ticks were positive to nested PCR for A. platys groEL gene. These results revealed the importance of searching for novel Anaplasma spp. closely related to A. platys in dogs and ticks. Seropositivity to a commercial immunochromatographic test SNAP 4Dx Anaplasma sp. was not significantly associated with PCR positivity for A. platys but with infestation by ticks carrying A. platys (P<0.05). Accordingly, R. sanguineus may be involved in transmission of A. platys but may not act as a reservoir of E. canis and PCR results for 16S rDNA could be a problematic diagnostic index for A. platys infection.

The objective of this study was to assess the pharmacologic effect of continuously released recombinant human interferon-alpha (rHuIFN-alpha) in the liver, the target organ of chronic hepatitis B and C, using 2',5'-oligoadenylate synthetase (2',5'-OAS) activity as an indicator of an antiviral state. A cylindrical matrix prepared from tetraglycerol dipalmitate (TGDP), a polyglycerol ester of fatty acids (PGEF), released rHuIFN-alpha in a pseudo-zero-order manner for about 1 week after implantation into mice, without any major loss of rHuIFN-alpha biologic activity during the release period. To evaluate the pharmacologic effect of the rHuIFN-alpha continuously released from this type of matrix, we established a murine test system. Bolus injections of rHuIFN-alpha solution at three doses increased 2',5'-OAS activities in murine liver extract and serum in a dose-dependent manner, indicating that this system is suitable for evaluating rHuIFN-alpha activity. After subcutaneous insertion of TGDP-matrix implants containing 5.5x10(7) IU rHuIFN-alpha per animal, 2',5'-OAS activities in both liver extracts and serum increased rapidly and remained high for over 1 week. Subcutaneous injections of an equivalent total dose (5.0x10(7) IU/animal per week) of rHuIFN-alpha solution in three or seven fractions prolonged 2',5'-OAS activities compared with a single bolus injection. Comparing 2',5'-OAS activity on day 7 and the portion of the area under the 2',5'-OAS activity-time curve above the normal level (deltaAUC) between the TGDP-matrix implant and multiple injections of the solution revealed that continuously released rHuIFN-alpha has an effect almost equivalent to that of three or seven injections of the solution per week.